Last Updated: May 6, 2026

Ever - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


US Patents and Regulatory Information for ever

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biocon Pharma EVEROLIMUS everolimus TABLET;ORAL 214182-004 Feb 11, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma EVEROLIMUS everolimus TABLET;ORAL 207486-001 Jun 8, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Breckenridge EVEROLIMUS everolimus TABLET;ORAL 205432-003 May 20, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Biocon Pharma EVEROLIMUS everolimus TABLET;ORAL 216140-002 Apr 9, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novugen EVEROLIMUS everolimus TABLET;ORAL 219955-002 Oct 30, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.